IL22 and malignant colon neoplasm: Specifically, IL-22 was found to activate STAT3 in human colon cancer cells, resulting in the expression of the H3K9-specific N-methyltransferase DOT1L, which subsequently induced the expression of core stem cell genes such as SOX2, NANOG, and POU5F1.